Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 3

Sponsor Class

OTHER 180INDUSTRY 112NIH 22NETWORK 15OTHER_GOV 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Thoracic 2Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Sarcopenia 1Sarcoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Neoplasms 1Neoplasm Metastasis 1

Interventions

Capecitabine 9Bevacizumab 8tislelizumab 7Oxaliplatin 7Drug Therapy 7pembrolizumab 6Surgical Procedures, Operative 6Cisplatin 6Standard of Care 5Radiotherapy 5Laparoscopy 5Fluorouracil 5Docetaxel 5Carboplatin 5toripalimab 4Radiosurgery 4Leucovorin 4Exercise 4Epirubicin 4Cyclophosphamide 4pertuzumab 3durvalumab 3dalpiciclib 3atezolizumab 3anlotinib 3Saline Solution 3Rituximab 3Radiation 3Prednisone 3Population Groups 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER_GOV × durvalumab × 1 year × Clear all
NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed
603 enrolled
Sarcoma

Neoplasm Metastasis, Sarcoma

NCT03446547 2026-04-14

ASTEROID

Vastra Gotaland Region

Phase 2 Completed
106 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT07192926 2026-02-20

SARCO-CTI

Ankara Etlik City Hospital

Completed
131 enrolled
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Neoplasms, Sarcopenia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡